T cell receptor (TCR) engagement leads to activation-induced splicing of tumor necrosis factor (TNF) nuclear pre-mRNA

Journal of Experimental Medicine

Volumn 188, Issue 2, 1998, Pages 247-254

  Yang, Yang ^a   Chang, Ju Fay ^a   Parnes, Jane R ^a   Fathman, C Garrison ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Pre mRNA; RNA splicing; T cells; TNF; Transcription

Indexed keywords

MESSENGER RNA; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; FEMALE; GENE INDUCTION; HUMAN; MOUSE; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; RNA SPLICING; RNA TRANSLATION; T LYMPHOCYTE ACTIVATION;

ANIMALS; GENE EXPRESSION REGULATION; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; RECEPTORS, ANTIGEN, T-CELL; RNA PRECURSORS; RNA SPLICING; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031875615     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.2.247     Document Type: Article

References (34)

1. Tracy, K.J., and A. Cerami. 1993. Tumor necrosis factor, other cytokines and disease. Annu. Rev. Cell Biol. 9:317-343.
2. Goldfeld, A.E., J.L. Strominger, and C. Doyle. 1991. Human tumor necrosis factor α gene regulation in phorbol ester stimulated T and B cell lines. J. Exp. Med. 174:73-81.
3. Zheng, L., G. Fisher, R.E. Miller, J. Peschon, D.H. Lynch, and M.J. Lenardo. 1995. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature. 377:348-351.
4. Ferran, C., K. Sheehan, M. Dy, R. Schreiber, S. Merite, P. Landais, L.H. Noel, G. Grau, J. Bluestone, J.F. Bach, et al. 1990. Cytokine-related syndrome following injection of anti-CD3 monoclonal antibody: further evidence for transient in vivo T cell activation. Eur. J. Immunol. 20:509-515.
5. Alegre, M., P. Vandenabeele, V. Flamand, M. Moser, O. Leo, D. Abramowicz, J. Urbain, W. Fiers, and M. Goldman. 1990. Hypothermia and hypoglycemia induced by anti-CD3 monoclonal antibody in mice: role of tumor necrosis factor. Eur. J. Immunol. 20:707-710.
6. Chatenoud, L., C. Ferran, C. Legendre, I. Thouard, S. Merite, A. Reuter, Y. Gevaert, H. Kreis, P. Franchimont, and J.F. Bach. 1990. In vivo cell activation following OKT3 administration. Systemic cytokine release and modulation by corticosteroids. Transplantation. 49:697-702.
7. Lindstein, T., C.H. June, J.A. Ledbetter, G. Stella, and C.B. Thompson. 1989. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science. 244:339-343.
8. Han, J., T. Brown, and B. Beutler. 1990. Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J. Exp. Med. 171:465-175.
9. Jongeneel, C.V., A.N. Shakhov, S.A. Nedospasov, and J.C. Cerottini. 1989. Molecular control of tissue-specific expression at the mouse TNF locus. Eur. J. Immunol. 19:549-552.
10. Han, J.H., B. Beutler, and G. Huez. 1991. Complex regulation of tumor necrosis factor mRNA turnover in lipopolysaccharide-activated macrophages. Biochem. Biophys. Acta. 1090: 22-28.
11. Ulich, T.R., K. Guo, and J. del Castillo. 1989. Endotoxin-induced cytokine gene expression in vivo. I. Expression of tumor necrosis factor mRNA in visceral organs under physiologic conditions and during endotoxemia. Am. J. Pathol. 134:11-14.
12. Bazzoni, F., and B. Beutler. 1995. Comparative expression of TNF-α alleles from normal and autoimmune-prone MHC haplotypes. J. Inflamm. 45:106-114.
13. Beutler, B.A., I.W. Milsark, and A. Cerami. 1985. Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo. J. Immunol. 135:3972-3977.
14. Beutler, B., N. Krochin, I.W. Milsark, C. Luedke, and A. Cerami. 1986. Control of cachectin (tumor necrosis factor) synthesis: mechanisms ot endotoxin resistance. Science. 232: 977-980.
15. Jarrous, N., and R. Kaempfer. 1994. Induction of human interleukin-1 gene expression by retinoic acid and its regulation at processing of precursor transcripts. J. Biol. Chem. 269: 23141-23149.
16. Gerez, L., G. Arad, S. Efrat, M. Ketzinel, and R. Kaempfer. 1995. Post-transcriptional regulation of human interleukin-2 gene expression at processing of precursor transcripts. J. Biol. Chem. 270:19569-19575.
17. Sariban, E., K. Immura, R. Luebbers, and D. Kufe. 1988. Transcriptional and posttranscriptional regulation of tumor necrosis factor gene expression in human monocytes. J. Clin. Invest. 81:1506-1510.
18. Shakhov, A.N., and S.A. Nedospasov. 1987. Molecular cloning of genes coding for tumor necrosis factor. Complete nucleotide sequence of the genome copy of TNF-α in mice. Bioorg. Khim. 13:701-705.
19. Cho, E.A., M.P. Riley, A.L. Sillman, and H. Quill. 1993. Altered protein tyrosine phosphorylation in anergic Th1 cells. J. Immunol. 151:20-28.
20. 2+. Curr. Biol. 6:1642-1652.
21. Negrini, M., E. Silini, C., Kozak, Y. Tsujimoto, and C.M. Croce. 1987. Molecular analysis of mbcl-2: structure and expression of the murine gene homologous to the human gene involved in follicular lymphoma. Cell. 49:455-463.
22. Green, M.R. 1991. Biochemical mechanisms of constitutive and regulated pre-mRNA splicing. Annu. Rev. Cell Biol. 7: 559-599.
23. Siebel, C.W., A. Admon, and D.C. Rio. 1995. Soma-specific expression and cloning of PSI, a negative regulator of P element pre-mRNA splicing. Genes Dev. 9:269-283.
24. Trowbridge, I.S., and M.L. Thomas. 1994. CD45: an emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development. Annu. Rev. Immunol. 12:85-116.
25. Jarrous, N., F. Osman, and R. Kaempfer. 1996. 2-Aminopurine selectively inhibits splicing of tumor necrosis factor α mRNA. Mol. Cell Biol. 16:2814-2822.
26. Shaw, G., and R. Kamen. 1986. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell. 46:659-667.
27. Caput, D., B. Beutler, K. Hartog, R. Thayer, S. Brown-Shimer, and A. Cerami. 1986. Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc. Natl. Acad. Sci. USA. 83:1670-1674.
28. Brocke, S., A. Gaur, C. Piercy, A. Gautam, K. Gijbels, C.G. Fathman, and L. Steinman. 1993. Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen. Nature. 365:642-644.
29. Mueller, C., W. Held, M.A. Imboden, and C. Carnaud. 1995. Accelerated β-cell destruction in adoptively transferred autoimmune diabetes correlates with an increased expression of the genes coding for TNF-α and granzyme A in the intraislet infiltrates. Diabetes. 44:112-117.
30. Yang, X.D., R. Tisch, S.M. Singer, Z.A. Cao, R.S. Liblau, R.D. Schreiber, and H.O. McDevitt. 1994. Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J. Exp. Med. 180:995-1004.
31. Baumann, H. and J. Gauldie. 1994. The acute phase response. Immunol. Today. 15:74-80.
32. Flynn, J.L., M.M. Goldstein, J. Chan, K.J. Triebold, K. Pfeffer, C.J. Lowenstein, R. Schreiber, T.W. Mak, and B.R., Bloom. 1995. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity. 2:561-572.
33. Kolls, J.K., D. Lei, S. Nelson, W.R. Summer, S. Greenberg, and B. Beutler. 1995. Adenovirus-mediated blockade of tumor necrosis factor in mice protects against endotoxic shock yet impairs pulmonary host defense. J. Infect. Dis. 171:570-575.
34. Litton, M.J., B. Sander, E. Murphy, A. O'Garra, and J.S. Abrams. 1994. Early expression of cytokines in lymph nodes after treatment in vivo with Staphylococcus enterotoxin B. J. Immunol. Methods. 175:47-58.